The two products accounted for about 48% of Eli Lilly's most recent quarterly sales and drove most of the top-line growth.

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Influencers on TikTok have been banned after they were found to be promoting drugs like Ozempic and Mounjaro through their social media ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

Estonian residents spent more on weight-loss drugs like Ozempic than any other medication last year, with one in every 50 ...

Louisiana is facing a significant obesity challenge, ranking fourth in the nation for obesity rates. As a result, many residents are turning to weight loss drugs like ...

People using Ozempic say they are losing their desire to drink. It’s anecdotal evidence right now, but this would be a game-changer for those who are trying to break free from addiction.

Novo Nordisk plans to initiate late-stage trials for its next-gen weight-loss drug, amycretin, by early 2026. The drug mimics ...

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

Lottie Moss revealed she 'felt like I was dying' after suffering seizure from an Ozempic overdose in a new episode of Olivia ...